Latest Breaking News On - Rentschler biotechnologie gmb - Page 4 : comparemela.com

GENEVA (BUSINESS WIRE) Jun 1, 2021 Selexis SA, a JSR Life Sciences company, has named seasoned business development executive Roland Hoffmann-Hecht, PhD, as its new chief business officer. As a member of the company’s executive leadership team, Dr. Hoffmann-Hecht will be responsible for all corporate and business development activities and will report directly to Selexis Chief Executive Officer Dirk Lange. (Photo: Business Wire) “We are fortunate to welcome Roland to our executive leadership team given his expansive career in contract development and manufacturing organizations (CDMOs) serving the biopharmaceuticals industry and demonstrated success building valuable relationships with partners,” said Mr. Lange. “His highly relevant skills and experience, coupled with his scientific and industry knowledge, will be invaluable to Selexis as we bolster our leading position in cell line development and ensure the continued success of our “Gene-to-GMP in 9 Mon

Switzerland generalRentschler biotechnologie gmbPolpharma biologicsDirk langeRobert meisterMike beyerRoland hoffmann hechtUniversity of homburgSam brown incInstitute for human geneticsCompany inquiries for selexisCorporate communicationsLife sciencesSelexis chief executive officer dirkBusiness wireRentschler biotechnologie